From: Stereoselective synthesis, X-ray analysis, computational studies and biological evaluation of new thiazole derivatives as potential anticancer agents
S. no
Sample concentration (μg/mL) viability  %
50
25
12.5
6.25
3.125
1.56
0
IC50 (μg)
Ref. D.
23.08
27.35
43.59
53.85
69.23
82.54
100
5.38
6
39.43
58.15
79.51
86.42
92.63
96.47
35.9
11
23.81
42.96
60.34
74.89
86.93
94.57
19.9